nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisdexamfetamine—Labetalol—hypertension	0.148	0.573	CrCtD
Lisdexamfetamine—attention deficit hyperactivity disorder—Guanfacine—hypertension	0.124	0.697	CpDpCtD
Lisdexamfetamine—Lisinopril—hypertension	0.11	0.427	CrCtD
Lisdexamfetamine—SLC6A2—hypertension	0.0953	0.663	CbGaD
Lisdexamfetamine—attention deficit hyperactivity disorder—Clonidine—hypertension	0.0542	0.303	CpDpCtD
Lisdexamfetamine—SLC6A3—hypertension	0.0485	0.337	CbGaD
Lisdexamfetamine—SLC18A2—Reserpine—hypertension	0.0395	0.256	CbGbCtD
Lisdexamfetamine—SLC6A2—Guanadrel—hypertension	0.025	0.163	CbGbCtD
Lisdexamfetamine—Lisinopril—Fosinopril—hypertension	0.0191	0.114	CrCrCtD
Lisdexamfetamine—SLC6A2—Guanethidine—hypertension	0.019	0.123	CbGbCtD
Lisdexamfetamine—Lisinopril—Moexipril—hypertension	0.0166	0.0991	CrCrCtD
Lisdexamfetamine—Phenacemide—Guanfacine—hypertension	0.0145	0.0864	CrCrCtD
Lisdexamfetamine—Lisinopril—Quinapril—hypertension	0.0137	0.0821	CrCrCtD
Lisdexamfetamine—Lisinopril—Benazepril—hypertension	0.0134	0.0801	CrCrCtD
Lisdexamfetamine—ADRA1B—Terazosin—hypertension	0.0126	0.0817	CbGbCtD
Lisdexamfetamine—ADRA1B—Fenoldopam—hypertension	0.0114	0.0739	CbGbCtD
Lisdexamfetamine—Lisinopril—Trandolapril—hypertension	0.0113	0.0676	CrCrCtD
Lisdexamfetamine—Lisinopril—Enalapril—hypertension	0.0113	0.0676	CrCrCtD
Lisdexamfetamine—Aspartame—Quinapril—hypertension	0.0109	0.0652	CrCrCtD
Lisdexamfetamine—ADRA1B—Doxazosin—hypertension	0.0105	0.0682	CbGbCtD
Lisdexamfetamine—Aspartame—Enalapril—hypertension	0.00899	0.0537	CrCrCtD
Lisdexamfetamine—Aspartame—Trandolapril—hypertension	0.00899	0.0537	CrCrCtD
Lisdexamfetamine—ADRA1B—Prazosin—hypertension	0.00863	0.056	CbGbCtD
Lisdexamfetamine—Lisinopril—Ramipril—hypertension	0.00858	0.0512	CrCrCtD
Lisdexamfetamine—Labetalol—Quinapril—hypertension	0.00817	0.0488	CrCrCtD
Lisdexamfetamine—Labetalol—Benazepril—hypertension	0.00797	0.0476	CrCrCtD
Lisdexamfetamine—ADRA1B—Carvedilol—hypertension	0.00745	0.0484	CbGbCtD
Lisdexamfetamine—ADRA1B—Nicardipine—hypertension	0.00745	0.0484	CbGbCtD
Lisdexamfetamine—Aspartame—Lisinopril—hypertension	0.00703	0.042	CrCrCtD
Lisdexamfetamine—Aspartame—Ramipril—hypertension	0.00681	0.0407	CrCrCtD
Lisdexamfetamine—ADRA1B—Clonidine—hypertension	0.00654	0.0425	CbGbCtD
Lisdexamfetamine—SLC6A2—Clonidine—hypertension	0.00597	0.0388	CbGbCtD
Lisdexamfetamine—ADRA1B—vas deferens—hypertension	0.00462	0.413	CbGeAlD
Lisdexamfetamine—SLC6A2—locus ceruleus—hypertension	0.00161	0.143	CbGeAlD
Lisdexamfetamine—SLC6A2—sympathetic nervous system—hypertension	0.00127	0.113	CbGeAlD
Lisdexamfetamine—SLC6A2—autonomic nervous system—hypertension	0.000853	0.0761	CbGeAlD
Lisdexamfetamine—SLC18A2—brainstem—hypertension	0.000337	0.0301	CbGeAlD
Lisdexamfetamine—Lisinopril—ACE2—hypertension	0.00029	0.239	CrCbGaD
Lisdexamfetamine—ADRA1B—kidney—hypertension	0.000272	0.0243	CbGeAlD
Lisdexamfetamine—SLC6A3—brainstem—hypertension	0.000255	0.0228	CbGeAlD
Lisdexamfetamine—SLC18A2—medulla oblongata—hypertension	0.000235	0.021	CbGeAlD
Lisdexamfetamine—SLC18A2—adrenal gland—hypertension	0.000218	0.0194	CbGeAlD
Lisdexamfetamine—SLC6A2—brainstem—hypertension	0.000206	0.0184	CbGeAlD
Lisdexamfetamine—SLC18A2—endocrine gland—hypertension	0.000189	0.0169	CbGeAlD
Lisdexamfetamine—SLC6A2—decidua—hypertension	0.000173	0.0155	CbGeAlD
Lisdexamfetamine—ADRA1B—central nervous system—hypertension	0.000172	0.0153	CbGeAlD
Lisdexamfetamine—SLC18A2—central nervous system—hypertension	0.00017	0.0152	CbGeAlD
Lisdexamfetamine—SLC6A2—medulla oblongata—hypertension	0.000144	0.0128	CbGeAlD
Lisdexamfetamine—SLC6A2—adrenal gland—hypertension	0.000133	0.0119	CbGeAlD
Lisdexamfetamine—SLC6A3—central nervous system—hypertension	0.000129	0.0115	CbGeAlD
Lisdexamfetamine—SLC6A2—endocrine gland—hypertension	0.000115	0.0103	CbGeAlD
Lisdexamfetamine—Phenelzine—ABAT—hypertension	0.000112	0.092	CrCbGaD
Lisdexamfetamine—SLC6A2—central nervous system—hypertension	0.000104	0.00927	CbGeAlD
Lisdexamfetamine—L-Phenylalanine—TH—hypertension	8.41e-05	0.0693	CrCbGaD
Lisdexamfetamine—Dextroamphetamine—SLC6A2—hypertension	7.26e-05	0.0599	CrCbGaD
Lisdexamfetamine—Methamphetamine—ADRA2B—hypertension	6.17e-05	0.0509	CrCbGaD
Lisdexamfetamine—Lisinopril—ACE—hypertension	6.13e-05	0.0506	CrCbGaD
Lisdexamfetamine—Lacosamide—CA9—hypertension	5.95e-05	0.049	CrCbGaD
Lisdexamfetamine—Amphetamine—SLC6A2—hypertension	5.85e-05	0.0483	CrCbGaD
Lisdexamfetamine—Methamphetamine—SLC6A2—hypertension	5.42e-05	0.0447	CrCbGaD
Lisdexamfetamine—Dextroamphetamine—ADRA1A—hypertension	5.11e-05	0.0422	CrCbGaD
Lisdexamfetamine—Labetalol—ADRB1—hypertension	4.82e-05	0.0398	CrCbGaD
Lisdexamfetamine—Labetalol—ADRB2—hypertension	4.06e-05	0.0335	CrCbGaD
Lisdexamfetamine—Dextroamphetamine—SLC6A3—hypertension	3.69e-05	0.0305	CrCbGaD
Lisdexamfetamine—Phenelzine—CYP3A5—hypertension	3.29e-05	0.0271	CrCbGaD
Lisdexamfetamine—Amphetamine—SLC6A3—hypertension	2.98e-05	0.0246	CrCbGaD
Lisdexamfetamine—Methamphetamine—SLC6A3—hypertension	2.76e-05	0.0227	CrCbGaD
Lisdexamfetamine—Methamphetamine—ADRA2A—hypertension	2.7e-05	0.0223	CrCbGaD
Lisdexamfetamine—Amphetamine—SLC6A4—hypertension	2.23e-05	0.0184	CrCbGaD
Lisdexamfetamine—Amphetamine—DRD2—hypertension	2.21e-05	0.0183	CrCbGaD
Lisdexamfetamine—Methamphetamine—SLC6A4—hypertension	2.06e-05	0.017	CrCbGaD
Lisdexamfetamine—Rash—Indapamide—hypertension	1.38e-05	0.000236	CcSEcCtD
Lisdexamfetamine—Rash—Diltiazem—hypertension	1.38e-05	0.000236	CcSEcCtD
Lisdexamfetamine—Dermatitis—Diltiazem—hypertension	1.38e-05	0.000236	CcSEcCtD
Lisdexamfetamine—Dermatitis—Indapamide—hypertension	1.38e-05	0.000236	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Losartan—hypertension	1.38e-05	0.000236	CcSEcCtD
Lisdexamfetamine—Vomiting—Carvedilol—hypertension	1.38e-05	0.000236	CcSEcCtD
Lisdexamfetamine—Dizziness—Verapamil—hypertension	1.38e-05	0.000235	CcSEcCtD
Lisdexamfetamine—Constipation—Betaxolol—hypertension	1.38e-05	0.000235	CcSEcCtD
Lisdexamfetamine—Headache—Indapamide—hypertension	1.37e-05	0.000235	CcSEcCtD
Lisdexamfetamine—Headache—Diltiazem—hypertension	1.37e-05	0.000235	CcSEcCtD
Lisdexamfetamine—Dry mouth—Ramipril—hypertension	1.37e-05	0.000234	CcSEcCtD
Lisdexamfetamine—Rash—Carvedilol—hypertension	1.37e-05	0.000234	CcSEcCtD
Lisdexamfetamine—Dermatitis—Carvedilol—hypertension	1.37e-05	0.000234	CcSEcCtD
Lisdexamfetamine—Anxiety—Timolol—hypertension	1.37e-05	0.000233	CcSEcCtD
Lisdexamfetamine—Angioedema—Lisinopril—hypertension	1.37e-05	0.000233	CcSEcCtD
Lisdexamfetamine—Vomiting—Doxazosin—hypertension	1.36e-05	0.000233	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Losartan—hypertension	1.36e-05	0.000233	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	1.36e-05	0.000233	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Clonidine—hypertension	1.36e-05	0.000233	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Captopril—hypertension	1.36e-05	0.000233	CcSEcCtD
Lisdexamfetamine—Headache—Carvedilol—hypertension	1.36e-05	0.000232	CcSEcCtD
Lisdexamfetamine—Rash—Doxazosin—hypertension	1.35e-05	0.000231	CcSEcCtD
Lisdexamfetamine—Fatigue—Losartan—hypertension	1.35e-05	0.000231	CcSEcCtD
Lisdexamfetamine—Dermatitis—Doxazosin—hypertension	1.35e-05	0.000231	CcSEcCtD
Lisdexamfetamine—Vomiting—Fosinopril—hypertension	1.35e-05	0.00023	CcSEcCtD
Lisdexamfetamine—Nausea—Propranolol—hypertension	1.34e-05	0.00023	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Ramipril—hypertension	1.34e-05	0.00023	CcSEcCtD
Lisdexamfetamine—Headache—Doxazosin—hypertension	1.34e-05	0.00023	CcSEcCtD
Lisdexamfetamine—Dry mouth—Timolol—hypertension	1.34e-05	0.000229	CcSEcCtD
Lisdexamfetamine—Constipation—Losartan—hypertension	1.34e-05	0.000229	CcSEcCtD
Lisdexamfetamine—Vomiting—Eplerenone—hypertension	1.34e-05	0.000229	CcSEcCtD
Lisdexamfetamine—Rash—Fosinopril—hypertension	1.34e-05	0.000228	CcSEcCtD
Lisdexamfetamine—Dermatitis—Fosinopril—hypertension	1.34e-05	0.000228	CcSEcCtD
Lisdexamfetamine—Vomiting—Nifedipine—hypertension	1.33e-05	0.000227	CcSEcCtD
Lisdexamfetamine—Rash—Eplerenone—hypertension	1.33e-05	0.000227	CcSEcCtD
Lisdexamfetamine—Urticaria—Perindopril—hypertension	1.33e-05	0.000227	CcSEcCtD
Lisdexamfetamine—Headache—Fosinopril—hypertension	1.33e-05	0.000227	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Trandolapril—hypertension	1.33e-05	0.000227	CcSEcCtD
Lisdexamfetamine—Dermatitis—Eplerenone—hypertension	1.33e-05	0.000227	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Valsartan—hypertension	1.33e-05	0.000227	CcSEcCtD
Lisdexamfetamine—Asthenia—Clonidine—hypertension	1.33e-05	0.000227	CcSEcCtD
Lisdexamfetamine—Vomiting—Verapamil—hypertension	1.32e-05	0.000226	CcSEcCtD
Lisdexamfetamine—Urticaria—Irbesartan—hypertension	1.32e-05	0.000226	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Enalapril—hypertension	1.32e-05	0.000226	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Perindopril—hypertension	1.32e-05	0.000226	CcSEcCtD
Lisdexamfetamine—Palpitations—Lisinopril—hypertension	1.32e-05	0.000226	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Olmesartan—hypertension	1.32e-05	0.000226	CcSEcCtD
Lisdexamfetamine—Headache—Eplerenone—hypertension	1.32e-05	0.000226	CcSEcCtD
Lisdexamfetamine—Rash—Nifedipine—hypertension	1.32e-05	0.000225	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Ramipril—hypertension	1.32e-05	0.000225	CcSEcCtD
Lisdexamfetamine—Dermatitis—Nifedipine—hypertension	1.32e-05	0.000225	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Irbesartan—hypertension	1.32e-05	0.000225	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Timolol—hypertension	1.31e-05	0.000225	CcSEcCtD
Lisdexamfetamine—Rash—Verapamil—hypertension	1.31e-05	0.000224	CcSEcCtD
Lisdexamfetamine—Urticaria—Hydrochlorothiazide—hypertension	1.31e-05	0.000224	CcSEcCtD
Lisdexamfetamine—Tachycardia—Ramipril—hypertension	1.31e-05	0.000224	CcSEcCtD
Lisdexamfetamine—Dermatitis—Verapamil—hypertension	1.31e-05	0.000224	CcSEcCtD
Lisdexamfetamine—Headache—Nifedipine—hypertension	1.31e-05	0.000224	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Hydrochlorothiazide—hypertension	1.31e-05	0.000223	CcSEcCtD
Lisdexamfetamine—Skin disorder—Ramipril—hypertension	1.31e-05	0.000223	CcSEcCtD
Lisdexamfetamine—Headache—Verapamil—hypertension	1.3e-05	0.000223	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Telmisartan—hypertension	1.3e-05	0.000223	CcSEcCtD
Lisdexamfetamine—Nausea—Diltiazem—hypertension	1.3e-05	0.000222	CcSEcCtD
Lisdexamfetamine—Nausea—Indapamide—hypertension	1.3e-05	0.000222	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Ramipril—hypertension	1.3e-05	0.000222	CcSEcCtD
Lisdexamfetamine—Asthenia—Trandolapril—hypertension	1.29e-05	0.000221	CcSEcCtD
Lisdexamfetamine—Urticaria—Furosemide—hypertension	1.29e-05	0.000221	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Timolol—hypertension	1.29e-05	0.00022	CcSEcCtD
Lisdexamfetamine—Nausea—Carvedilol—hypertension	1.29e-05	0.00022	CcSEcCtD
Lisdexamfetamine—Asthenia—Enalapril—hypertension	1.29e-05	0.00022	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Furosemide—hypertension	1.28e-05	0.00022	CcSEcCtD
Lisdexamfetamine—Dizziness—Valsartan—hypertension	1.28e-05	0.000219	CcSEcCtD
Lisdexamfetamine—Anorexia—Ramipril—hypertension	1.28e-05	0.000219	CcSEcCtD
Lisdexamfetamine—Urticaria—Betaxolol—hypertension	1.28e-05	0.000218	CcSEcCtD
Lisdexamfetamine—Skin disorder—Timolol—hypertension	1.28e-05	0.000218	CcSEcCtD
Lisdexamfetamine—Dizziness—Olmesartan—hypertension	1.28e-05	0.000218	CcSEcCtD
Lisdexamfetamine—Nausea—Doxazosin—hypertension	1.27e-05	0.000218	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Betaxolol—hypertension	1.27e-05	0.000217	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Timolol—hypertension	1.27e-05	0.000217	CcSEcCtD
Lisdexamfetamine—Asthenia—Telmisartan—hypertension	1.27e-05	0.000217	CcSEcCtD
Lisdexamfetamine—Anxiety—Lisinopril—hypertension	1.27e-05	0.000217	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Clonidine—hypertension	1.26e-05	0.000216	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	1.26e-05	0.000216	CcSEcCtD
Lisdexamfetamine—Nausea—Fosinopril—hypertension	1.26e-05	0.000215	CcSEcCtD
Lisdexamfetamine—Anorexia—Timolol—hypertension	1.25e-05	0.000214	CcSEcCtD
Lisdexamfetamine—Nausea—Eplerenone—hypertension	1.25e-05	0.000214	CcSEcCtD
Lisdexamfetamine—Urticaria—Losartan—hypertension	1.25e-05	0.000213	CcSEcCtD
Lisdexamfetamine—Dry mouth—Lisinopril—hypertension	1.24e-05	0.000213	CcSEcCtD
Lisdexamfetamine—Nausea—Nifedipine—hypertension	1.24e-05	0.000212	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Losartan—hypertension	1.24e-05	0.000212	CcSEcCtD
Lisdexamfetamine—Nausea—Verapamil—hypertension	1.24e-05	0.000211	CcSEcCtD
Lisdexamfetamine—Asthenia—Captopril—hypertension	1.24e-05	0.000211	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Trandolapril—hypertension	1.23e-05	0.000211	CcSEcCtD
Lisdexamfetamine—Vomiting—Valsartan—hypertension	1.23e-05	0.000211	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Enalapril—hypertension	1.23e-05	0.00021	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Irbesartan—hypertension	1.23e-05	0.00021	CcSEcCtD
Lisdexamfetamine—Vomiting—Olmesartan—hypertension	1.23e-05	0.00021	CcSEcCtD
Lisdexamfetamine—Rash—Valsartan—hypertension	1.22e-05	0.000209	CcSEcCtD
Lisdexamfetamine—Dizziness—Clonidine—hypertension	1.22e-05	0.000209	CcSEcCtD
Lisdexamfetamine—Dermatitis—Valsartan—hypertension	1.22e-05	0.000209	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Lisinopril—hypertension	1.22e-05	0.000208	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Hydrochlorothiazide—hypertension	1.22e-05	0.000208	CcSEcCtD
Lisdexamfetamine—Rash—Olmesartan—hypertension	1.22e-05	0.000208	CcSEcCtD
Lisdexamfetamine—Insomnia—Ramipril—hypertension	1.22e-05	0.000208	CcSEcCtD
Lisdexamfetamine—Dermatitis—Olmesartan—hypertension	1.22e-05	0.000208	CcSEcCtD
Lisdexamfetamine—Headache—Valsartan—hypertension	1.21e-05	0.000208	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Telmisartan—hypertension	1.21e-05	0.000207	CcSEcCtD
Lisdexamfetamine—Headache—Olmesartan—hypertension	1.21e-05	0.000207	CcSEcCtD
Lisdexamfetamine—Asthenia—Perindopril—hypertension	1.2e-05	0.000205	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Ramipril—hypertension	1.2e-05	0.000205	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Furosemide—hypertension	1.2e-05	0.000205	CcSEcCtD
Lisdexamfetamine—Asthenia—Irbesartan—hypertension	1.2e-05	0.000204	CcSEcCtD
Lisdexamfetamine—Somnolence—Ramipril—hypertension	1.2e-05	0.000204	CcSEcCtD
Lisdexamfetamine—Dizziness—Trandolapril—hypertension	1.19e-05	0.000204	CcSEcCtD
Lisdexamfetamine—Tachycardia—Lisinopril—hypertension	1.19e-05	0.000203	CcSEcCtD
Lisdexamfetamine—Insomnia—Timolol—hypertension	1.19e-05	0.000203	CcSEcCtD
Lisdexamfetamine—Dizziness—Enalapril—hypertension	1.19e-05	0.000203	CcSEcCtD
Lisdexamfetamine—Asthenia—Hydrochlorothiazide—hypertension	1.19e-05	0.000203	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Betaxolol—hypertension	1.19e-05	0.000203	CcSEcCtD
Lisdexamfetamine—Skin disorder—Lisinopril—hypertension	1.18e-05	0.000202	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Ramipril—hypertension	1.18e-05	0.000202	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Lisinopril—hypertension	1.18e-05	0.000201	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Captopril—hypertension	1.18e-05	0.000201	CcSEcCtD
Lisdexamfetamine—Vomiting—Clonidine—hypertension	1.18e-05	0.000201	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Timolol—hypertension	1.17e-05	0.0002	CcSEcCtD
Lisdexamfetamine—Dizziness—Telmisartan—hypertension	1.17e-05	0.0002	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Ramipril—hypertension	1.17e-05	0.0002	CcSEcCtD
Lisdexamfetamine—Somnolence—Timolol—hypertension	1.17e-05	0.0002	CcSEcCtD
Lisdexamfetamine—Asthenia—Furosemide—hypertension	1.17e-05	0.000199	CcSEcCtD
Lisdexamfetamine—Rash—Clonidine—hypertension	1.17e-05	0.000199	CcSEcCtD
Lisdexamfetamine—Dermatitis—Clonidine—hypertension	1.16e-05	0.000199	CcSEcCtD
Lisdexamfetamine—Anorexia—Lisinopril—hypertension	1.16e-05	0.000199	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Ramipril—hypertension	1.16e-05	0.000198	CcSEcCtD
Lisdexamfetamine—Fatigue—Ramipril—hypertension	1.16e-05	0.000198	CcSEcCtD
Lisdexamfetamine—Headache—Clonidine—hypertension	1.16e-05	0.000198	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Timolol—hypertension	1.16e-05	0.000198	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Losartan—hypertension	1.16e-05	0.000197	CcSEcCtD
Lisdexamfetamine—Asthenia—Betaxolol—hypertension	1.15e-05	0.000197	CcSEcCtD
Lisdexamfetamine—Nausea—Valsartan—hypertension	1.15e-05	0.000197	CcSEcCtD
Lisdexamfetamine—Constipation—Ramipril—hypertension	1.15e-05	0.000196	CcSEcCtD
Lisdexamfetamine—Nausea—Olmesartan—hypertension	1.15e-05	0.000196	CcSEcCtD
Lisdexamfetamine—Vomiting—Trandolapril—hypertension	1.15e-05	0.000196	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Perindopril—hypertension	1.14e-05	0.000195	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Timolol—hypertension	1.14e-05	0.000195	CcSEcCtD
Lisdexamfetamine—Vomiting—Enalapril—hypertension	1.14e-05	0.000195	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Irbesartan—hypertension	1.14e-05	0.000195	CcSEcCtD
Lisdexamfetamine—Dizziness—Captopril—hypertension	1.14e-05	0.000195	CcSEcCtD
Lisdexamfetamine—Rash—Trandolapril—hypertension	1.14e-05	0.000194	CcSEcCtD
Lisdexamfetamine—Dermatitis—Trandolapril—hypertension	1.14e-05	0.000194	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Timolol—hypertension	1.13e-05	0.000194	CcSEcCtD
Lisdexamfetamine—Fatigue—Timolol—hypertension	1.13e-05	0.000194	CcSEcCtD
Lisdexamfetamine—Rash—Enalapril—hypertension	1.13e-05	0.000193	CcSEcCtD
Lisdexamfetamine—Dermatitis—Enalapril—hypertension	1.13e-05	0.000193	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Hydrochlorothiazide—hypertension	1.13e-05	0.000193	CcSEcCtD
Lisdexamfetamine—Headache—Trandolapril—hypertension	1.13e-05	0.000193	CcSEcCtD
Lisdexamfetamine—Vomiting—Telmisartan—hypertension	1.13e-05	0.000192	CcSEcCtD
Lisdexamfetamine—Asthenia—Losartan—hypertension	1.13e-05	0.000192	CcSEcCtD
Lisdexamfetamine—Headache—Enalapril—hypertension	1.12e-05	0.000192	CcSEcCtD
Lisdexamfetamine—Rash—Telmisartan—hypertension	1.12e-05	0.000191	CcSEcCtD
Lisdexamfetamine—Dermatitis—Telmisartan—hypertension	1.12e-05	0.000191	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Furosemide—hypertension	1.11e-05	0.00019	CcSEcCtD
Lisdexamfetamine—Headache—Telmisartan—hypertension	1.11e-05	0.00019	CcSEcCtD
Lisdexamfetamine—Dizziness—Perindopril—hypertension	1.11e-05	0.000189	CcSEcCtD
Lisdexamfetamine—Insomnia—Lisinopril—hypertension	1.1e-05	0.000188	CcSEcCtD
Lisdexamfetamine—Dizziness—Irbesartan—hypertension	1.1e-05	0.000188	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Betaxolol—hypertension	1.1e-05	0.000188	CcSEcCtD
Lisdexamfetamine—Nausea—Clonidine—hypertension	1.1e-05	0.000188	CcSEcCtD
Lisdexamfetamine—Vomiting—Captopril—hypertension	1.09e-05	0.000187	CcSEcCtD
Lisdexamfetamine—Dizziness—Hydrochlorothiazide—hypertension	1.09e-05	0.000187	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Lisinopril—hypertension	1.09e-05	0.000186	CcSEcCtD
Lisdexamfetamine—Rash—Captopril—hypertension	1.09e-05	0.000186	CcSEcCtD
Lisdexamfetamine—Dermatitis—Captopril—hypertension	1.08e-05	0.000185	CcSEcCtD
Lisdexamfetamine—Somnolence—Lisinopril—hypertension	1.08e-05	0.000185	CcSEcCtD
Lisdexamfetamine—Headache—Captopril—hypertension	1.08e-05	0.000184	CcSEcCtD
Lisdexamfetamine—Dizziness—Furosemide—hypertension	1.07e-05	0.000184	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Lisinopril—hypertension	1.07e-05	0.000183	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Losartan—hypertension	1.07e-05	0.000183	CcSEcCtD
Lisdexamfetamine—Nausea—Trandolapril—hypertension	1.07e-05	0.000183	CcSEcCtD
Lisdexamfetamine—Urticaria—Ramipril—hypertension	1.07e-05	0.000183	CcSEcCtD
Lisdexamfetamine—Nausea—Enalapril—hypertension	1.07e-05	0.000182	CcSEcCtD
Lisdexamfetamine—Dizziness—Betaxolol—hypertension	1.06e-05	0.000182	CcSEcCtD
Lisdexamfetamine—Vomiting—Perindopril—hypertension	1.06e-05	0.000182	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Ramipril—hypertension	1.06e-05	0.000182	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Lisinopril—hypertension	1.06e-05	0.000181	CcSEcCtD
Lisdexamfetamine—Vomiting—Irbesartan—hypertension	1.06e-05	0.000181	CcSEcCtD
Lisdexamfetamine—Rash—Perindopril—hypertension	1.05e-05	0.00018	CcSEcCtD
Lisdexamfetamine—Dermatitis—Perindopril—hypertension	1.05e-05	0.00018	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Lisinopril—hypertension	1.05e-05	0.00018	CcSEcCtD
Lisdexamfetamine—Nausea—Telmisartan—hypertension	1.05e-05	0.00018	CcSEcCtD
Lisdexamfetamine—Fatigue—Lisinopril—hypertension	1.05e-05	0.00018	CcSEcCtD
Lisdexamfetamine—Vomiting—Hydrochlorothiazide—hypertension	1.05e-05	0.00018	CcSEcCtD
Lisdexamfetamine—Rash—Irbesartan—hypertension	1.05e-05	0.00018	CcSEcCtD
Lisdexamfetamine—Dermatitis—Irbesartan—hypertension	1.05e-05	0.000179	CcSEcCtD
Lisdexamfetamine—Headache—Perindopril—hypertension	1.05e-05	0.000179	CcSEcCtD
Lisdexamfetamine—Urticaria—Timolol—hypertension	1.04e-05	0.000178	CcSEcCtD
Lisdexamfetamine—Headache—Irbesartan—hypertension	1.04e-05	0.000178	CcSEcCtD
Lisdexamfetamine—Constipation—Lisinopril—hypertension	1.04e-05	0.000178	CcSEcCtD
Lisdexamfetamine—Rash—Hydrochlorothiazide—hypertension	1.04e-05	0.000178	CcSEcCtD
Lisdexamfetamine—Dermatitis—Hydrochlorothiazide—hypertension	1.04e-05	0.000178	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Timolol—hypertension	1.04e-05	0.000178	CcSEcCtD
Lisdexamfetamine—Dizziness—Losartan—hypertension	1.04e-05	0.000177	CcSEcCtD
Lisdexamfetamine—Headache—Hydrochlorothiazide—hypertension	1.04e-05	0.000177	CcSEcCtD
Lisdexamfetamine—Vomiting—Furosemide—hypertension	1.03e-05	0.000177	CcSEcCtD
Lisdexamfetamine—Rash—Furosemide—hypertension	1.02e-05	0.000175	CcSEcCtD
Lisdexamfetamine—Dermatitis—Furosemide—hypertension	1.02e-05	0.000175	CcSEcCtD
Lisdexamfetamine—Vomiting—Betaxolol—hypertension	1.02e-05	0.000175	CcSEcCtD
Lisdexamfetamine—Nausea—Captopril—hypertension	1.02e-05	0.000175	CcSEcCtD
Lisdexamfetamine—Headache—Furosemide—hypertension	1.02e-05	0.000174	CcSEcCtD
Lisdexamfetamine—Rash—Betaxolol—hypertension	1.01e-05	0.000173	CcSEcCtD
Lisdexamfetamine—Dermatitis—Betaxolol—hypertension	1.01e-05	0.000173	CcSEcCtD
Lisdexamfetamine—Headache—Betaxolol—hypertension	1.01e-05	0.000172	CcSEcCtD
Lisdexamfetamine—Vomiting—Losartan—hypertension	9.97e-06	0.00017	CcSEcCtD
Lisdexamfetamine—Nausea—Perindopril—hypertension	9.93e-06	0.00017	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Ramipril—hypertension	9.91e-06	0.000169	CcSEcCtD
Lisdexamfetamine—Nausea—Irbesartan—hypertension	9.9e-06	0.000169	CcSEcCtD
Lisdexamfetamine—Rash—Losartan—hypertension	9.89e-06	0.000169	CcSEcCtD
Lisdexamfetamine—Dermatitis—Losartan—hypertension	9.88e-06	0.000169	CcSEcCtD
Lisdexamfetamine—Headache—Losartan—hypertension	9.82e-06	0.000168	CcSEcCtD
Lisdexamfetamine—Nausea—Hydrochlorothiazide—hypertension	9.82e-06	0.000168	CcSEcCtD
Lisdexamfetamine—Urticaria—Lisinopril—hypertension	9.69e-06	0.000166	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Timolol—hypertension	9.69e-06	0.000165	CcSEcCtD
Lisdexamfetamine—Nausea—Furosemide—hypertension	9.65e-06	0.000165	CcSEcCtD
Lisdexamfetamine—Asthenia—Ramipril—hypertension	9.65e-06	0.000165	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Lisinopril—hypertension	9.64e-06	0.000165	CcSEcCtD
Lisdexamfetamine—Nausea—Betaxolol—hypertension	9.56e-06	0.000163	CcSEcCtD
Lisdexamfetamine—Asthenia—Timolol—hypertension	9.43e-06	0.000161	CcSEcCtD
Lisdexamfetamine—Nausea—Losartan—hypertension	9.31e-06	0.000159	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Ramipril—hypertension	9.2e-06	0.000157	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Timolol—hypertension	8.99e-06	0.000154	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Lisinopril—hypertension	8.98e-06	0.000154	CcSEcCtD
Lisdexamfetamine—Dizziness—Ramipril—hypertension	8.89e-06	0.000152	CcSEcCtD
Lisdexamfetamine—Asthenia—Lisinopril—hypertension	8.75e-06	0.000149	CcSEcCtD
Lisdexamfetamine—Dizziness—Timolol—hypertension	8.69e-06	0.000149	CcSEcCtD
Lisdexamfetamine—Vomiting—Ramipril—hypertension	8.55e-06	0.000146	CcSEcCtD
Lisdexamfetamine—Rash—Ramipril—hypertension	8.48e-06	0.000145	CcSEcCtD
Lisdexamfetamine—Dermatitis—Ramipril—hypertension	8.47e-06	0.000145	CcSEcCtD
Lisdexamfetamine—Headache—Ramipril—hypertension	8.42e-06	0.000144	CcSEcCtD
Lisdexamfetamine—Vomiting—Timolol—hypertension	8.36e-06	0.000143	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Lisinopril—hypertension	8.34e-06	0.000143	CcSEcCtD
Lisdexamfetamine—Rash—Timolol—hypertension	8.29e-06	0.000142	CcSEcCtD
Lisdexamfetamine—Dermatitis—Timolol—hypertension	8.28e-06	0.000141	CcSEcCtD
Lisdexamfetamine—Headache—Timolol—hypertension	8.24e-06	0.000141	CcSEcCtD
Lisdexamfetamine—Dizziness—Lisinopril—hypertension	8.06e-06	0.000138	CcSEcCtD
Lisdexamfetamine—Nausea—Ramipril—hypertension	7.99e-06	0.000136	CcSEcCtD
Lisdexamfetamine—Nausea—Timolol—hypertension	7.81e-06	0.000133	CcSEcCtD
Lisdexamfetamine—Vomiting—Lisinopril—hypertension	7.75e-06	0.000132	CcSEcCtD
Lisdexamfetamine—Rash—Lisinopril—hypertension	7.69e-06	0.000131	CcSEcCtD
Lisdexamfetamine—Dermatitis—Lisinopril—hypertension	7.68e-06	0.000131	CcSEcCtD
Lisdexamfetamine—Headache—Lisinopril—hypertension	7.64e-06	0.000131	CcSEcCtD
Lisdexamfetamine—Nausea—Lisinopril—hypertension	7.24e-06	0.000124	CcSEcCtD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TACR2—hypertension	4.12e-06	0.000151	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—ADRA2A—hypertension	4.11e-06	0.000151	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—F2—hypertension	4.11e-06	0.000151	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—GHRL—hypertension	4.1e-06	0.00015	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—PPARA—hypertension	4.08e-06	0.00015	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CALCA—hypertension	4.05e-06	0.000148	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—EDNRB—hypertension	4.04e-06	0.000148	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—TAC1—hypertension	4e-06	0.000147	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADORA1—hypertension	3.96e-06	0.000145	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—BDKRB2—hypertension	3.95e-06	0.000145	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ANXA1—hypertension	3.92e-06	0.000144	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CXCR3—hypertension	3.92e-06	0.000144	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—ADRBK1—hypertension	3.91e-06	0.000143	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CNR1—hypertension	3.88e-06	0.000142	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—APOA1—hypertension	3.83e-06	0.00014	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PGF—hypertension	3.83e-06	0.00014	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NEDD4L—hypertension	3.83e-06	0.00014	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PPBP—hypertension	3.83e-06	0.00014	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR2B—hypertension	3.83e-06	0.00014	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—EDNRA—hypertension	3.82e-06	0.00014	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—SST—hypertension	3.82e-06	0.00014	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—hypertension	3.81e-06	0.000139	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ADRB1—hypertension	3.8e-06	0.000139	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—DRD3—hypertension	3.8e-06	0.000139	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR7—hypertension	3.79e-06	0.000139	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—DRD2—hypertension	3.79e-06	0.000139	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NFATC2—hypertension	3.76e-06	0.000138	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—LEPR—hypertension	3.76e-06	0.000138	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—hypertension	3.76e-06	0.000138	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—GCG—hypertension	3.75e-06	0.000137	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—POMC—hypertension	3.75e-06	0.000137	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ADRA2A—hypertension	3.74e-06	0.000137	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—GHRL—hypertension	3.72e-06	0.000136	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CALCA—hypertension	3.67e-06	0.000135	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CCL2—hypertension	3.67e-06	0.000134	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ATP2A3—hypertension	3.6e-06	0.000132	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PDE4A—hypertension	3.6e-06	0.000132	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—KNG1—hypertension	3.6e-06	0.000132	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—BDKRB2—hypertension	3.59e-06	0.000131	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—AGTR1—hypertension	3.57e-06	0.000131	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ADRBK1—hypertension	3.55e-06	0.00013	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CNR1—hypertension	3.52e-06	0.000129	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—INHBA—hypertension	3.5e-06	0.000128	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ARHGDIA—hypertension	3.5e-06	0.000128	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADRA1A—hypertension	3.5e-06	0.000128	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CXCL10—hypertension	3.49e-06	0.000128	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CALM2—hypertension	3.49e-06	0.000128	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ROCK2—hypertension	3.45e-06	0.000126	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—DRD2—hypertension	3.44e-06	0.000126	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR7—hypertension	3.44e-06	0.000126	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—ALB—hypertension	3.43e-06	0.000125	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—GCG—hypertension	3.4e-06	0.000125	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—ADRB2—hypertension	3.39e-06	0.000124	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—AVPR1A—hypertension	3.37e-06	0.000123	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CYSLTR1—hypertension	3.37e-06	0.000123	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PRKCE—hypertension	3.35e-06	0.000123	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—LHB—hypertension	3.33e-06	0.000122	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—VAV3—hypertension	3.31e-06	0.000121	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RGS2—hypertension	3.29e-06	0.00012	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GAL—hypertension	3.29e-06	0.00012	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—KNG1—hypertension	3.27e-06	0.00012	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—VIP—hypertension	3.25e-06	0.000119	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—UTS2—hypertension	3.25e-06	0.000119	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TRH—hypertension	3.25e-06	0.000119	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CRHR1—hypertension	3.25e-06	0.000119	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CMA1—hypertension	3.25e-06	0.000119	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GNRH1—hypertension	3.25e-06	0.000119	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—AGTR1—hypertension	3.25e-06	0.000119	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—GNB3—hypertension	3.23e-06	0.000118	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—AVP—hypertension	3.19e-06	0.000117	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CXCL10—hypertension	3.17e-06	0.000116	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—OXTR—hypertension	3.15e-06	0.000115	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—GNAS—hypertension	3.14e-06	0.000115	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TRPC3—hypertension	3.12e-06	0.000114	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CX3CR1—hypertension	3.12e-06	0.000114	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CASR—hypertension	3.12e-06	0.000114	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—LRP2—hypertension	3.12e-06	0.000114	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ADRB2—hypertension	3.08e-06	0.000113	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—BDKRB1—hypertension	3.06e-06	0.000112	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HDAC6—hypertension	3.06e-06	0.000112	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CX3CL1—hypertension	3.06e-06	0.000112	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PRKCE—hypertension	3.04e-06	0.000111	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—ALB—hypertension	3.04e-06	0.000111	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—EDN1—hypertension	3.03e-06	0.000111	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CCL5—hypertension	3.01e-06	0.00011	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—VAV3—hypertension	3e-06	0.00011	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HSPG2—hypertension	3e-06	0.00011	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GABBR1—hypertension	2.98e-06	0.000109	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PRKG1—hypertension	2.98e-06	0.000109	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PTH—hypertension	2.98e-06	0.000109	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADM—hypertension	2.98e-06	0.000109	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PDE4D—hypertension	2.98e-06	0.000109	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—GNB3—hypertension	2.93e-06	0.000107	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CYBB—hypertension	2.9e-06	0.000106	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TACR1—hypertension	2.9e-06	0.000106	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GLP1R—hypertension	2.9e-06	0.000106	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CXCL8—hypertension	2.9e-06	0.000106	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—AVP—hypertension	2.89e-06	0.000106	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hypertension	2.89e-06	0.000106	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—ADCY5—hypertension	2.88e-06	0.000105	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PRKCG—hypertension	2.86e-06	0.000105	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—GNAS—hypertension	2.86e-06	0.000105	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HRH3—hypertension	2.85e-06	0.000104	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PRKCA—hypertension	2.84e-06	0.000104	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—EDN1—hypertension	2.75e-06	0.000101	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCL5—hypertension	2.73e-06	0.0001	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PRKCD—hypertension	2.71e-06	9.92e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CCR5—hypertension	2.71e-06	9.92e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NCF2—hypertension	2.65e-06	9.71e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR2A—hypertension	2.65e-06	9.71e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—C3—hypertension	2.65e-06	9.69e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ADCY5—hypertension	2.61e-06	9.57e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PRKCG—hypertension	2.6e-06	9.51e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NPY—hypertension	2.58e-06	9.47e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—VWF—hypertension	2.58e-06	9.47e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PRKCA—hypertension	2.58e-06	9.44e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—AGT—hypertension	2.52e-06	9.21e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR1B—hypertension	2.49e-06	9.13e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CXCL2—hypertension	2.49e-06	9.13e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—AGTR2—hypertension	2.49e-06	9.13e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—OXT—hypertension	2.49e-06	9.13e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TGFBR1—hypertension	2.47e-06	9.03e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—F2R—hypertension	2.47e-06	9.03e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PRKCD—hypertension	2.46e-06	9.01e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCR5—hypertension	2.46e-06	9.01e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR2A—hypertension	2.41e-06	8.82e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—C3—hypertension	2.4e-06	8.8e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NCF1—hypertension	2.39e-06	8.75e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—EDNRB—hypertension	2.39e-06	8.75e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TAC1—hypertension	2.36e-06	8.66e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PRKCB—hypertension	2.32e-06	8.51e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—F2—hypertension	2.32e-06	8.51e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ANXA1—hypertension	2.32e-06	8.49e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CXCR3—hypertension	2.32e-06	8.49e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IKBKB—hypertension	2.3e-06	8.41e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—AGT—hypertension	2.28e-06	8.36e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—SST—hypertension	2.26e-06	8.26e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—EDNRA—hypertension	2.26e-06	8.26e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CALM1—hypertension	2.25e-06	8.22e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADRB1—hypertension	2.25e-06	8.22e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CYBA—hypertension	2.25e-06	8.22e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—DRD3—hypertension	2.25e-06	8.22e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—FLT1—hypertension	2.25e-06	8.22e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADRA2A—hypertension	2.21e-06	8.08e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GHRL—hypertension	2.2e-06	8.05e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PLAT—hypertension	2.2e-06	8.05e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CALCA—hypertension	2.17e-06	7.95e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—BDKRB2—hypertension	2.12e-06	7.76e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—POMC—hypertension	2.12e-06	7.75e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—F2—hypertension	2.11e-06	7.73e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PRKCB—hypertension	2.11e-06	7.73e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADRBK1—hypertension	2.1e-06	7.68e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CNR1—hypertension	2.08e-06	7.62e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CALM2—hypertension	2.06e-06	7.54e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—AKT2—hypertension	2.04e-06	7.45e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—DRD2—hypertension	2.03e-06	7.44e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR7—hypertension	2.03e-06	7.44e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GCG—hypertension	2.01e-06	7.36e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PTPN1—hypertension	2.01e-06	7.36e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NOTCH2—hypertension	1.97e-06	7.22e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—KL—hypertension	1.97e-06	7.22e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NGFR—hypertension	1.93e-06	7.09e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ITGAV—hypertension	1.93e-06	7.09e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—KNG1—hypertension	1.93e-06	7.06e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—POMC—hypertension	1.92e-06	7.04e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PRL—hypertension	1.92e-06	7.02e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—AGTR1—hypertension	1.92e-06	7.02e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HDAC1—hypertension	1.89e-06	6.92e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—STK11—hypertension	1.89e-06	6.92e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCL2—hypertension	1.88e-06	6.89e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CXCL10—hypertension	1.87e-06	6.86e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PLG—hypertension	1.87e-06	6.84e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—RHOA—hypertension	1.87e-06	6.83e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—AKT2—hypertension	1.85e-06	6.77e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PIK3R1—hypertension	1.85e-06	6.76e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADRB2—hypertension	1.82e-06	6.66e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PRKCE—hypertension	1.8e-06	6.58e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PDGFA—hypertension	1.77e-06	6.5e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—VAV3—hypertension	1.77e-06	6.5e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TGFBR2—hypertension	1.75e-06	6.4e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GNB3—hypertension	1.73e-06	6.34e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—AVP—hypertension	1.71e-06	6.26e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—RHOA—hypertension	1.69e-06	6.2e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GNAS—hypertension	1.69e-06	6.18e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PIK3R1—hypertension	1.68e-06	6.14e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—APOB—hypertension	1.65e-06	6.05e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PTK2—hypertension	1.65e-06	6.02e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CXCL8—hypertension	1.64e-06	6e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—EDN1—hypertension	1.63e-06	5.95e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCL5—hypertension	1.61e-06	5.91e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—LPL—hypertension	1.58e-06	5.78e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—H2AFX—hypertension	1.57e-06	5.73e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PDGFRB—hypertension	1.56e-06	5.72e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RPS6KB1—hypertension	1.56e-06	5.72e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADCY5—hypertension	1.54e-06	5.65e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PRKCG—hypertension	1.53e-06	5.62e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PRKCA—hypertension	1.52e-06	5.58e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ITGB3—hypertension	1.52e-06	5.58e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—YWHAZ—hypertension	1.51e-06	5.53e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—SPP1—hypertension	1.49e-06	5.47e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NGF—hypertension	1.49e-06	5.47e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CXCL8—hypertension	1.49e-06	5.45e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PRKCD—hypertension	1.45e-06	5.32e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCR5—hypertension	1.45e-06	5.32e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR2A—hypertension	1.42e-06	5.21e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—C3—hypertension	1.42e-06	5.2e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PDGFB—hypertension	1.38e-06	5.06e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—FGFR1—hypertension	1.38e-06	5.04e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HIF1A—hypertension	1.35e-06	4.96e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—AGT—hypertension	1.35e-06	4.94e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CALM1—hypertension	1.33e-06	4.86e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—APOE—hypertension	1.32e-06	4.84e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—LEP—hypertension	1.32e-06	4.84e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CAV1—hypertension	1.31e-06	4.8e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—APOA1—hypertension	1.31e-06	4.79e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—KDR—hypertension	1.3e-06	4.74e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—F2—hypertension	1.25e-06	4.57e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—FN1—hypertension	1.25e-06	4.57e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PRKCB—hypertension	1.25e-06	4.57e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NOTCH1—hypertension	1.22e-06	4.47e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—POMC—hypertension	1.14e-06	4.16e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—INS—hypertension	1.13e-06	4.14e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCL2—hypertension	1.11e-06	4.07e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IGF1—hypertension	1.09e-06	4e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—AKT2—hypertension	1.09e-06	4e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—EGFR—hypertension	1.09e-06	3.98e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—SERPINE1—hypertension	1.04e-06	3.8e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—FGF2—hypertension	1e-06	3.68e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RHOA—hypertension	1e-06	3.66e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PIK3R1—hypertension	9.91e-07	3.63e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NOS3—hypertension	9.91e-07	3.63e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RELA—hypertension	9.32e-07	3.41e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MTOR—hypertension	9.14e-07	3.35e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CXCL8—hypertension	8.79e-07	3.22e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—AKT1—hypertension	8.49e-07	3.11e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—IL6—hypertension	8.35e-07	3.06e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MMP9—hypertension	7.95e-07	2.91e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CDKN1A—hypertension	7.92e-07	2.9e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PTEN—hypertension	7.9e-07	2.89e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MAPK8—hypertension	7.73e-07	2.83e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—AKT1—hypertension	7.71e-07	2.82e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—EP300—hypertension	7.53e-07	2.76e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—SRC—hypertension	7.33e-07	2.68e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—VEGFA—hypertension	7.14e-07	2.61e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MYC—hypertension	6.57e-07	2.4e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TGFB1—hypertension	6.55e-07	2.4e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—EGFR—hypertension	6.42e-07	2.35e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TP53—hypertension	5.39e-07	1.97e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IL6—hypertension	4.94e-07	1.81e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—AKT1—hypertension	4.55e-07	1.67e-05	CbGpPWpGaD
